Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor
Author(s) -
Hatice Aldemir,
Virginie Prod’homme,
Marie-Jeanne Dumaurier,
Christelle Retière,
Gwénola Poupon,
Julie Cazareth,
Franck Bihl,
Véronique M. Braud
Publication year - 2005
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.175.12.7791
Subject(s) - receptor , lectin , microbiology and biotechnology , biology , c type lectin , t cell receptor , secretion , cytotoxic t cell , ligand (biochemistry) , t cell , immunology , in vitro , biochemistry , immune system
Human NK cells and subsets of T cells or NKT cells express the orphan C-type lectin receptor CD161 (NKR-P1A) of unknown function. In contrast to rodents that possess several NKR-P1 genes coding for either activating or inhibitory receptors, the nature of signals delivered by the single human NKR-P1A receptor is still to be clarified. In this article, we show that the lectin-like transcript 1 (LLT1) molecule is a ligand for the CD161 receptor. Engagement of CD161 on NK cells with LLT1 expressed on target cells inhibited NK cell-mediated cytotoxicity and IFN-gamma secretion. Conversely, LLT1/CD161 interaction in the presence of a TCR signal enhanced IFN-gamma production by T cells. These findings identify a novel ligand/receptor pair that differentially regulate NK and T cell functions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom